Transgene SA (TRGNF)
1.00
0.00 (0.00%)
USD |
OTCM |
Apr 24, 16:00
Transgene Market Cap : 132.29M for April 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nicox SA | 24.28M |
| DBV Technologies SA | 1.088B |
| Cellectis SA | 391.30M |
| Adocia SA | 231.08M |
| Innate Pharma SA | 132.27M |
Market Cap Related Metrics
| PS Ratio | 957.41 |
| PEG Ratio | -0.163 |
| Price to Book Value | 0.7206 |
| Price | 1.00 |
| Earnings Yield | -29.20% |
| PEGY Ratio | -0.163 |